Physician profile
Joseph Broucek
NPI 1982990982
$261,602.57
in general payments reported to CMS, 2019-2025
7 companies · $55K in 2025
The $55K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34K · 2020: $22K · 2021: $8,000 · 2022: $44K · 2023: $45K · 2024: $54K · 2025: $55K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $124K · Travel and Lodging: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,500 · Food and Beverage: $3,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $124,100.00 |
| Travel and Lodging | $19,950.43 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,500.00 |
| Food and Beverage | $3,650.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $251,810.05 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Covidien LP | $9,099.72 | 2019 | |
| Polynovo North America LLC | $179.57 | 2025 | Novosorb Btm |
| W. L. Gore & Associates, INC. | $174.49 | 2024-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Bioxcel Therapeutics, INC. | $141.66 | 2024 | Igalmi |
| Ethicon US, LLC | $101.54 | 2019 | |
| Tela Bio, INC. | $95.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Broucek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.